Discrimination Against People with OUD in Skilled Nursing Facilities: New Commentary Calls Healthcare Providers to Action
In a recently published commentary for Annals of Internal Medicine, “Ending Medical Complicity with Skilled Nursing Facility Discrimination Against People with Opioid Use Disorder,” Shawn M. Cohen, MD, instructor (general medicine) and faculty in the Yale Program in Addiction Medicine, along with co-authors from the University of Washington, Boston Medical Center, and the Legal Action Center, describe discriminatory admissions practices in skilled nursing facilities (SNFs) limiting access to care for people with opioid use disorder.
Does Immunotherapy Offer Survival Gain in Older NSCLC Patients?
Immune checkpoint inhibitors are used at nearly the same rates in younger and older patients with non–small cell lung cancer (NSCLC), yet the survival benefit observed in younger patients does not appear to extend to older individuals, who represent the majority of patients.Source: Medscape
Students Organize Auction to Support Local Nonprofits Focused on Hunger & Homelessness
“The man. The myth. The bowtie.” When auctioneer Jaideep Talwalkar, MD, associate professor of internal medicine (general medicine) and assistant dean for education, called out these words at Yale School of Medicine’s (YSM) 29th Annual Hunger & Homelessness (H&H) Charity Auction on the evening of January 19, it led to a bidding frenzy from the crowd gathered in the school’s Café Med.
Older Patients Left Behind in Progress Against Lung Cancer, Yale Study Shows
Although widespread use of immune checkpoint inhibitors (ICIs) in patients with advanced lung cancer has led to meaningful improvements in survival in younger patients, older patients have not experienced similar survival benefits, new research from Yale Cancer Center shows. The study was published in JAMA Oncology.
Survival gains with checkpoint inhibitors differ ‘drastically’ between age groups in NSCLC
Despite significantly extending survival for younger adults with advanced non-small cell lung cancer, immune checkpoint inhibitors have conferred only modest OS gains over time among patients aged older than 75 years, study results showed.Source: Healio
Loophole Enables FDA Approval of Unsafe Medical Devices, Yale Study Finds
New Yale research finds that many medical devices subject to recall had received FDA approval based, in part, on the products’ similarities to earlier devices which had also been subject to recalls, including an intra-aortic balloon pump used in patients hospitalized for heart failure.Source: YaleNews
Weight Loss Patches May Be Trendy, But They Can Cause Serious Side Effects
If you’ve recently looked up ways to lose weight, you’ve likely come across tons of supplements and aids that promise quick results (remember waist trainers, anyone?). And most of these products are total B.S. (sorry!), but one continues to draw attention: weight loss patches.Source: Yahoo! Sports
Three Department of Internal Medicine Staff Retiring
Three Department of Internal Medicine staff are set to retire. Kathleen Marcucio from the Section of Endocrinology & Metabolism retired on December 31, 2022. Susan Ardito from the Section of Pulmonary, Critical Care & Sleep Medicine (Yale-PCCSM), and Elizabeth “Beth” Porter from the Section of General Internal Medicine retire in January 2023.
9 ways to curb your drinking habits, according to addiction specialists
In light of new research, experts are saying Americans should cut back on drinking. A new study found that 20% of deaths in 20- to 49-year-olds from 2015 to 2019 were linked to alcohol use. Here are nine tips on how to curb your drinking, according to addiction specialists.Source: Insider
Yale Internal Medicine Faculty Partner with Formerly Incarcerated Leaders to Obtain R01
The COVID-19 pandemic has had a disproportionate impact on many people in underserved communities, including those who are incarcerated or work in our nation’s prison systems. Infections across this community have been five times higher than in the general U.S. population. Surrounding communities have also been disproportionately affected.
Congress Should Take This Chance to Fix Clinical Trial Diversity
Yale School of Medicine’s Jennifer Miller, Reshma Ramachandran, and Tanvee Varma say Congress should advance clinical trial diversity and social justice in its year-end spending bill. Clinical trials usually underrepresent women, older adults, and minorities, creating uncertainty about drug safety, they say.Source: Bloomberg Law
Weight-loss drugs are a milestone for the obese but expose health inequity
Designed for diabetes but used for obesity at higher doses, the medications induce loss of 15 to 22 percent of body weight on average — more than enough to significantly reduce cardiovascular and other health risks. That makes them far superior to old-style diet pills that delivered smaller benefits along with nasty side effects such as high blood pressure and loose stools.Source: Washington Post